StocksSpringWorks Therapeutics IncSWTX

SWTX

SpringWorks Therapeutics Inc

66.21 -4.65 (-6.56%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
66.16
B
66.40

Overview

Prev Close66.21
Day's Range65.54 - 70.80
52 Week Range51.72 - 96.48
Average Volume (3m)324.75K
1-Year Return-1.98%
Beta1.1102
Market Cap3.26B
P/E Ratio
Revenue35M
EPS-2.193
Dividend (Yield) (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.722/06/202103/09/202115/11/202155.0060.0065.0070.0075.0080.0085.0090.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Saqib Islam
Employees 78

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: SpringWorks Therapeutics Inc's revenues increased by ∞% and amounted to 35.00M. Net income increased by 21.84% to -45.57M. Net assets increased by 72.96% to 557.06M and EPS increased from -1.18 to -1.05.
SWTX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-32.55%
Operating Margin
-304.15%
Return On Investment
-28.47%
12/20
03/21
06/21
09/21
Total Revenue
35M
0
0
0
Gross Profit
N/A
-367K
-360K
-362K
Operating Income
11.22M
-29.76M
-47.02M
-40.9M
Net Income
11.27M
-29.79M
-47.01M
-41.04M